| Patient | Josephine Baker |
|---|---|
| Date of birth | 1906-06-03 |
| Identifiers | MRN HR-ML049-SYN-TD; SSN (made up) 000-49-3172 |
| Document date | 1969-10-20 |
| Author | Colette Ashby-Nwosu, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Seven-month review: antiplatelet plan, blood pressure and screening results. [S]
Ms. Baker returns five weeks after her preventive visit. She has sung and danced in six concerts over the past month, resting between shows, without chest pain, breathlessness or palpitations, and she has not needed nitroglycerin. Her home blood pressure averages 120/74. She has had no further nosebleeds and no other bleeding. Her screening results: the FIT was negative, the mammogram was normal, and the hepatitis C and HIV tests were negative. The bone density scan showed osteopenia (lowest T-score -1.7 at the femoral neck) with a ten-year fracture risk below the level at which medicine is advised. The optometrist found no disease. She asks how long she must take clopidogrel. [S]
| Element | Detail |
|---|---|
| Performing | Six concerts in a month without symptoms |
| Home blood pressure | Average 120/74 mmHg |
| Screening | FIT, mammogram, hepatitis C and HIV negative; osteopenia below the treatment threshold |
| Seattle Angina Questionnaire-7 | 96 |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations or lightheadedness |
| Respiratory | Negative | No breathlessness on stage or on stairs |
| Hematologic/lymphatic | Negative | No bleeding or unusual bruising |
| Musculoskeletal | Negative | Knees stiff after long shows; no falls |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 | active | S |
| Ticagrelor 90 mg oral tablet, one tablet twice daily | One tablet twice daily | Oral route | 1969-03-24 to 1969-04-28 | completed | S |
| Clopidogrel 75 mg oral tablet: a 600 mg loading dose (eight tablets) 24 hours after the last ticagrelor, then one tablet daily | One tablet daily after a 600 mg loading dose | Oral route | 1969-04-28 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 | active | S |
| Metoprolol succinate 25 mg extended-release oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 | active | S |
| Lisinopril 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1969-03-24 to 1969-04-28 | completed | S |
| Lisinopril 10 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1969-04-28 | active | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if the pain is not better 5 minutes after the first tablet | One tablet under the tongue every 5 minutes as needed for chest pain, up to 3 doses | Sublingual route | 1969-03-24 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1969-10-20 | Body height | 168 | cm | S |
| 1969-10-20 | Body weight | 60.6 | kg | S |
| 1969-10-20 | Body mass index (BMI) [Ratio] | 21.5 | kg/m2 | S |
| 1969-10-20 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1969-10-20 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1969-10-20 | Heart rate | 58 | /min | S |
| 1969-10-20 | Respiratory rate | 14 | /min | S |
| 1969-10-20 | Body temperature | 36.6 | Cel | S |
| 1969-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1969-10-20 | Hemoglobin [Mass/volume] in Blood | 12.4 | g/dL | 11.6-15 g/dL | Normal | S |
| 1969-10-20 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1969-10-20 | Potassium [Moles/volume] in Serum or Plasma | 4.5 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1969-10-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.84 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1969-10-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M | 78 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1969-10-20 | Glucose [Mass/volume] in Serum or Plasma | 93 | mg/dL | 70-99 mg/dL | Normal | S |
| 1969-10-20 | Overall summary score [SAQ] | 96 | {score} | S |
Vital signs recorded on 1969-10-20; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 122/74, pulse 58; weight 60.6 kg |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear |
| Extremities | No edema |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness on exertion and tiredness since discharge three weeks after the heart attack, without chest pain at rest; cause to be determined (heart function, ischemia, anemia, medicine effect or deconditioning) | resolved | confirmed | R06.09 | S — Synthetic presenting problem, resolved at the second visit when the echocardiogram and cardiology attributed it to ticagrelor. |
| Coronary artery disease after a non-ST-elevation myocardial infarction three weeks before intake, treated with one drug-eluting stent to the right coronary artery; synthetic modern episode linked to the documented heart attack of March 1912 | active | confirmed | I25.10 | S — Synthetic modern diagnosis; the 1969 heart attack remains D in the history. |
| High blood pressure, found during the hospital stay for the heart attack | active | confirmed | I10 | S — Synthetic modern diagnosis; no claim about her real blood pressure. |
| Absence of the uterus after an emergency hysterectomy at about 35, during a long, grave illness after the loss of a pregnancy; whether the ovaries were removed is not known; counted as a possible early menopause when weighing her cardiovascular risk | active | provisional | Z90.710 | S — Synthetic modern status linked to the retrospective account of a hysterectomy in 1941 or 1942; the operation itself rests on one secondary source. |
| Breathlessness from ticagrelor: a common, harmless side effect, resolved after the change to clopidogrel | resolved | confirmed | T45.525A | S — Synthetic diagnosis at the second visit; resolved at the third visit after the switch. |
| Raised lipoprotein(a), 172 nmol/L, an inherited risk-enhancing factor | active | confirmed | E78.41 | S — Synthetic result measured once at the second visit. |
| Financial strain: heavy debts after the loss of her home and estate, with income only from performing, which she has stopped while she recovers | active | confirmed | Z59.86 | S — Synthetic social need anchored to her documented debts and the loss of Les Milandes. |
| Anterior nosebleed from the left side of the nose, lasting about 25 minutes, in dry weather on aspirin and clopidogrel; stopped with pressure; no further bleeding | resolved | confirmed | R04.0 | S — Synthetic intercurrent problem at an unscheduled visit; it follows from dual antiplatelet therapy and does not echo a documented illness. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure (seated, average of two readings; home readings) | Every visit | Completed today | 122/74 mmHg; home average 120/74 |
| Examination | Weight, BMI and physical activity | Every visit | Completed today | 60.6 kg; six concerts in a month |
| Medication safety | Adherence: aspirin and P2Y12 inhibitor through the dual antiplatelet window, high-intensity statin, beta-blocker, ACE inhibitor | Every visit | Completed today | No missed doses; clopidogrel to stop at twelve months, aspirin to continue |
| Medication safety | Bleeding on dual antiplatelet therapy (symptoms, hemoglobin when indicated) | Every visit | Completed today | No bleeding since the nosebleed in June; hemoglobin 12.4 g/dL, platelets not repeated |
| Laboratory | Metabolic panel (potassium, creatinine, eGFR) on an ACE inhibitor | Every six to twelve months when stable | Completed today | Sodium 139, potassium 4.5, creatinine 0.84 mg/dL (eGFR 78), glucose 93 |
| Laboratory | Lipid panel | Every three to twelve months when stable | Up to date | LDL 62 mg/dL in July; next at about one year |
| Laboratory | Hemoglobin A1c (no diabetes) | Yearly screening | Up to date | 5.6% in April; due at one year |
| Survey | Angina status (Seattle Angina Questionnaire-7) | At intake and every few months in the first year | Completed today | 96 |
| Survey | Depression screen (PHQ-2, then PHQ-9) | After the infarction and periodically | Up to date | PHQ-2 0 at the preventive visit |
| Examination | Stress testing or repeat angiography | Not for routine surveillance | Not indicated | No symptoms; routine repeat testing is not recommended |
| Imaging | Echocardiogram for left ventricular function | After the infarction if not done or if function was reduced; then only with clinical change | Not indicated | No clinical change |
| Examination | Influenza, COVID-19 and RSV vaccination review | Yearly | Completed today | Influenza, COVID-19 and PCV20 at the preventive visit; RSV, zoster dose 1 and Tdap today |
| Self-management | Self-management: chest-pain action plan, nitroglycerin, women's warning symptoms | Every visit | Completed today | Nitroglycerin in the dressing room; not needed |
Goal progress:
Immunizations given today: Respiratory syncytial virus vaccine, single dose; Recombinant zoster vaccine, dose 1 of 2; Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) [S]
Guideline basis: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and acute myocardial infarction monographs (2026); Osteoporosis to Prevent Fractures: Screening (2025); Adult Immunization Schedule by Age (2026)
Follow-up: RSV vaccine, zoster dose 1 and Tdap given today; second zoster dose in two to six months. Review in about three months, before clopidogrel stops at twelve months. Call 911 for chest pain not relieved five minutes after one nitroglycerin. [S]